- Home
- MCBS vs CMPS Comparison
MCBS vs CMPS Comparison
Compare MCBS & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCBS | CMPS |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 816.1M | 724.5M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MCBS | CMPS |
|---|---|---|
| Price | $31.41 | $9.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $33.00 | $26.57 |
| AVG Volume (30 Days) | 81.7K | ★ 4.3M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.17% | N/A |
| EPS Growth | ★ 4.76 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.78 | N/A |
| Revenue Next Year | $2.44 | N/A |
| P/E Ratio | $11.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.53 | $2.25 |
| 52 Week High | $33.08 | $10.21 |
Technical Indicators
Market Signals| Indicator | MCBS | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 60.34 | 74.48 |
| Support Level | $28.51 | $4.56 |
| Resistance Level | $33.08 | N/A |
| Average True Range (ATR) | 0.68 | 0.63 |
| MACD | 0.01 | 0.44 |
| Stochastic Oscillator | 48.86 | 84.90 |
Price Performance
Historical ComparisonAbout MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.